The Anti-Emetic Efficiacy of Intravenous Dolasetron Mesilate plus Dexamethasone versus Intravenous Dolasetron Mesilate Alone in Patients Receiving Fractionated Chemotherapy

Publisher: Karger

E-ISSN: 2296-5262|22|2|140-144

ISSN: 2296-5270

Source: Oncology Research and Treatment, Vol.22, Iss.2, 1999-05, pp. : 140-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract